Concepedia
Statistics
Publications
7
Citations
427
H-Index
Active since
2014
Affiliations
Pfizer (United States)(Current)
Allogene Therapeutics (United States)
AIR Worldwide (United States)
Zea Melton is an author at Pfizer (United States) specializing in immunology, antibody engineering, and immunotherapy.
Top concepts
MedicineImmunologyImmunotherapyAntibody EngineeringProteomicsBioinformaticsNatural SciencesMolecular BiologyFunctional GenomicsProtein Engineering
Publications per year
2014–2023
Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
Shih-Hsun Chen, Pawel K. Dominik, Jessica Stanfield et al. · Journal for ImmunoTherapy of Cancer · 2021 · 133 citations · Full text
Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma
Siler H. Panowski, Surabhi Srinivasan, Nguyêñ Duy Tân et al. · Cancer Research · 2022 · 84 citations
Precise and Efficient Antibody Epitope Determination through Library Design, Yeast Display and Next-Generation Sequencing
Thomas Van Blarcom, Andrea Rossi, Davide Foletti et al. · Journal of Molecular Biology · 2014 · 66 citations
Bioinformatics, Immunocytochemical Technique, Library Design +13
Direct control of CAR T cells through small molecule-regulated antibodies
Spencer Park, Edward Pascua, Kevin C. Lindquist et al. · Nature Communications · 2021 · 47 citations · Full text
Adaptive Immune System, T-regulatory Cell, Immunology +19
Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer
Yi Zhang, Silvia K. Tacheva-Grigorova, Janette Sutton et al. · Clinical Cancer Research · 2023 · 46 citations
1–5 of 7